Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP678173.RAK75KSv_VjEf94gDadS5_pDl4SM0yU9DrpdI9g_yL32c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP678173.RAK75KSv_VjEf94gDadS5_pDl4SM0yU9DrpdI9g_yL32c130_assertion type Assertion NP678173.RAK75KSv_VjEf94gDadS5_pDl4SM0yU9DrpdI9g_yL32c130_head.
- NP678173.RAK75KSv_VjEf94gDadS5_pDl4SM0yU9DrpdI9g_yL32c130_assertion description "[From these data we conclude that the occurrence of CDKN2 (p16/MTS1) mutation in primary breast cancer is a rare event and is not likely to be involved in human breast tumour carcinogenesis and progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678173.RAK75KSv_VjEf94gDadS5_pDl4SM0yU9DrpdI9g_yL32c130_provenance.
- NP678173.RAK75KSv_VjEf94gDadS5_pDl4SM0yU9DrpdI9g_yL32c130_assertion evidence source_evidence_literature NP678173.RAK75KSv_VjEf94gDadS5_pDl4SM0yU9DrpdI9g_yL32c130_provenance.
- NP678173.RAK75KSv_VjEf94gDadS5_pDl4SM0yU9DrpdI9g_yL32c130_assertion SIO_000772 7547249 NP678173.RAK75KSv_VjEf94gDadS5_pDl4SM0yU9DrpdI9g_yL32c130_provenance.
- NP678173.RAK75KSv_VjEf94gDadS5_pDl4SM0yU9DrpdI9g_yL32c130_assertion wasDerivedFrom befree-20150227 NP678173.RAK75KSv_VjEf94gDadS5_pDl4SM0yU9DrpdI9g_yL32c130_provenance.
- NP678173.RAK75KSv_VjEf94gDadS5_pDl4SM0yU9DrpdI9g_yL32c130_assertion wasGeneratedBy ECO_0000203 NP678173.RAK75KSv_VjEf94gDadS5_pDl4SM0yU9DrpdI9g_yL32c130_provenance.